Fractyl Health (GUTS) Assets Average (2024 - 2026)
Fractyl Health (GUTS) reported Assets Average of $110.4 million for Q1 2026, up 15.52% year-on-year from $95.6 million in Q1 2025, and down 6.32% quarter-over-quarter from $117.8 million in Q4 2025.
Fractyl Health (GUTS) has 3 years of Assets Average data on file, last reported at $110.4 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 15.52% year-over-year to $110.4 million; the trailing twelve-month figure through Mar 2026 stood at $110.4 million (up 15.52% YoY), and the FY2025 full-year result was $114.7 million, up 24.52% from the prior year.
- Assets Average for Q1 2026 stood at $110.4 million, down from $117.8 million in the prior quarter.
- Across five years, Assets Average topped out at $155.0 million in Q2 2024 and bottomed at $72.5 million in Q2 2025.
- A 3-year average of $112.6 million and a median of $117.5 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average sank 53.2% in 2025 and advanced 15.52% in 2026, its largest moves.
- Tracing GUTS's Assets Average over 3 years: stood at $117.5 million in 2024, then increased by 0.29% to $117.8 million in 2025, then retreated by 6.32% to $110.4 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $110.4 million, $117.8 million, and $88.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 40.71 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 26.03 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 110.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.39 Mn |
| Dec 31, 2025 | 117.84 Mn |
| Sep 30, 2025 | 88.14 Mn |
| Jun 30, 2025 | 72.52 Mn |
| Mar 31, 2025 | 95.56 Mn |
| Dec 31, 2024 | 117.50 Mn |
| Sep 30, 2024 | 136.68 Mn |
| Jun 30, 2024 | 154.98 Mn |
| Mar 31, 2024 | 119.87 Mn |